Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Soil Transmitted Helminthiasis (STH)

PHASE3RecruitingINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

February 14, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

December 31, 2026

Conditions

Soil-Transmitted Helminthiasis (STH)

Interventions

DRUG

ZP5-9676 600 mg dose

oral, chewable tablet formulation of flubendazole

DRUG

Placebo

Matching placebo

Trial Locations (1)

RECRUITING

Clínica de Vacinas, Americaninha

All Listed Sponsors

lead

Zero Point Five Therapeutics

INDUSTRY